Recent Advances in Plasmepsin Medicinal Chemistry and Implications for Future Antimalarial Drug Discovery Efforts
- 1 March 2012
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Topics in Medicinal Chemistry
- Vol. 12 (5) , 445-455
Abstract
Plasmepsins are the aspartic proteases of Plasmodium that play key roles in the survival of the parasite in its host. The plasmepsins of the digestive vacuole play an important role in hemoglobin degradation, providing the parasite with a vital source of nutrients. Recently, plasmepsin V has been shown to be an essential protease, processing hundreds of parasite proteins for export into the host erythrocyte. The functions of the remaining plasmepsins have yet to be discovered. Over the past decade, much effort has been placed towards developing plasmepsin inhibitors as antimalarial agents, particularly targeting the digestive vacuole. This review will highlight some of the recent work in this field with a particular focus on target druggability and strategies for identifying plasmepsins inhibitors as effective antimalarial drugs. Given recent advances in understanding the fundamental roles of the various plasmepsins, it is likely that the most effective antimalarial plasmepsin targets will be the non-digestive vacuole plasmepsins.Keywords
This publication has 61 references indexed in Scilit:
- Four plasmepsins are active in thePlasmodium falciparumfood vacuole, including a protease with an active-site histidineProceedings of the National Academy of Sciences, 2002
- Piperidine-renin inhibitors compounds with improved physicochemical propertiesBioorganic & Medicinal Chemistry Letters, 1999
- Substituted piperidines - highly potent renin inhibitors due to induced fit adaptation of the active siteBioorganic & Medicinal Chemistry Letters, 1999
- A distinct member of the aspartic proteinase gene family from the human malaria parasite Plasmodium falciparumFEBS Letters, 1999
- Renin inhibition by substituted piperidines: A novel paradigm for the inhibition of monomeric aspartic proteinases?Chemistry & Biology, 1999
- Antimalarial Synergy of Cysteine and Aspartic Protease InhibitorsAntimicrobial Agents and Chemotherapy, 1998
- Inhibition and catalytic mechanism of HIV-1 aspartic proteaseJournal of Molecular Biology, 1996
- Order and specificity of the Plasmodium falciparum hemoglobin degradation pathway.Journal of Clinical Investigation, 1994
- Plasmodium falciparum: Differential Sensitivity In Vitro to E‐64 (Cysteine Protease Inhibitor) and Pepstatin A (Aspartyl Protease Inhibitor)The Journal of Protozoology, 1992
- Hemoglobin degradation in the human malaria pathogen Plasmodium falciparum: a catabolic pathway initiated by a specific aspartic protease.Journal of Experimental Medicine, 1991